Mobile Medical App Whitepaper:

The FDA and European regulators encourage the development of mobile medical apps to enable patients to manage their own health and well-being, yet the regulatory status of a smartphone remains a source of confusion.

  • bulletpoint The regulatory requirements in the USA and EU
  • bulletpoint How regulators view Operating System upgrades
  • bulletpoint How to maintain validation of medical apps

Novarum DX, has produced a whitepaper available for download which provides guidance on the regulation of mobile medical apps:

Contact Novarum to learn more about the regulation centred around apps with a medical function and how Novarum can support your mHealth strategy via: